3BT-15255-47556
4 vaccinations
4 coded responses
42 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 972 / OR
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-14
- 2021-01-20
- 2021-01-27
-
2021-02-02
Dose 2 — Moderna
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-11
- 2021-03-16
-
2021-05-04
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Cold symptoms approx 5-6 weeks ago. Negative covid pcr test.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-27
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: Viral coldMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-29
Dose 3 — Moderna
- 2021-10-29
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-28
- 2021-12-03
- 2021-12-10
- 2022-01-30
- 2022-04-29
-
2022-10-25
Dose 4 — Pfizer-BioNTech
-
2022-10-29
Survey response — 12 months, dose 3MedDRA: Cough, Nasal congestion, Nasopharyngitis, Upper-airway cough syndrome — Feeling: FairFree text: Cold symptoms- nasal congestion/drip, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-11-02
-
2022-11-08
Survey response — day 14, dose 4MedDRA: Nasopharyngitis, Productive cough, Respiratory tract congestion — Feeling: FairFree text: Cold symptoms, productive cough, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-22
- 2022-11-29
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-02 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-10-25 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-04 | Unsuccessful |
Free text
Release 8 — 3 months, dose 2
Symptoms: Cold symptoms approx 5-6 weeks ago. Negative covid pcr test.
Release 9 — 6 months, dose 2
Symptoms: Viral cold
Release 12 — 12 months, dose 3
Symptoms: Cold symptoms- nasal congestion/drip, cough
Release 12 — day 14, dose 4
Symptoms: Cold symptoms, productive cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release